Patents by Inventor Luca Chiovato

Luca Chiovato has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability
    Patent number: 9592237
    Abstract: Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/ inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level.
    Type: Grant
    Filed: December 22, 2015
    Date of Patent: March 14, 2017
    Assignee: Fundacion Del Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion (FUHNPAIIN)
    Inventors: Antonio Oliviero, Juan de Los Reyes Aguilar Lepe, Mario Rotondi, Eduardo Molina Holgado, Luca Chiovato, Guglielmo Foffani, Laura Mordillo Mateos, Angel Lozano Sicilia, Daniel Garcia Ovejero, Angel Arevalo Martin, Yolanda Perez Borrego
  • Use of CB1 Antagonists and/or Inverse Agonists for the Preparation of Drugs that Increase Motor Neuron Excitability
    Publication number: 20160106752
    Abstract: Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/ inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level.
    Type: Application
    Filed: December 22, 2015
    Publication date: April 21, 2016
    Applicant: Fundacion Del Hospital Nacional De Paraplejicos Para La Investigacion Y La Integracion (FUHNPAIIN)
    Inventors: Antonio Oliviero, Juan de Los Reyes Aguilar Lepe, Mario Rotondi, Eduardo Molina Holgado, Luca Chiovato, Guglielmo Foffani, Laura Mordillo Mateos, Angel Lozano Sicilia, Daniel Garcia Ovejero, Angel Arevalo Martin, Yolanda Perez Borrego
  • Use of CB1 antagonists and/or inverse agonists for the preparation of drugs that increase motor neuron excitability
    Patent number: 9238027
    Abstract: Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level.
    Type: Grant
    Filed: January 11, 2010
    Date of Patent: January 19, 2016
    Assignee: Fundacion del Hospital Nacional de Paraplejicos para la investigacion y la integracion (Fuhnpaiin)
    Inventors: Antonio Oliviero, Juan de los Reyes Aguilar Lepe, Mario Rotondi, Eduardo Molina Holgado, Luca Chiovato, Guglielmo Foffani, Laura Mordillo Mateos, Ángel Lozano Sicilia, Daniel García Ovejero, Ángel Arévalo Martín, Yolanda Pérez Borrego
  • USE OF CB1 ANTAGONISTS AND/OR INVERSE AGONISTS FOR THE PREPARATION OF DRUGS THAT INCREASE MOTOR NEURON EXCITABILITY
    Publication number: 20120015945
    Abstract: Use of a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for the preparation of drugs useful for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level, as well as a method for increasing motor neuron excitability through the administration of a CB1 antagonist/inverse agonist receptors, and to the use of a pharmaceutical composition which comprises a CB1 receptor antagonist and/or inverse agonist, preferably rimonabant, for increasing motor neuron excitability in the cerebral cortex and/or in the brain stem and/or at the spinal level.
    Type: Application
    Filed: January 11, 2010
    Publication date: January 19, 2012
    Inventors: Antonio Oliviero, Juan de los Reyes Aguilar Lepe, Mario Rotondi, Eduardo Molina Holgado, Luca Chiovato, Guglielmo Foffani, Laura Mordillo Mateos, Ángel Lozano Sicilia, Daniel García Ovejero, Ángel Arévalo Martín, Yolanda Pérez Borrego